Patents by Inventor Javed Baqai

Javed Baqai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100209532
    Abstract: A method of delivering oxygen to a tissue, a blood vessel, an organ, or a region of an organ, under an ischemic condition, or prophylactically preventing occurrence of an ischemic condition, of a subject, comprising the step of administering to the subject an oxygenated hemoglobin solution, wherein the oxygenated hemoglobin solution includes polymerized hemoglobin, and wherein about 80% by weight, or greater, of the polymerized hemoglobin is oxyhemoglobin.
    Type: Application
    Filed: June 13, 2008
    Publication date: August 19, 2010
    Applicant: OPK BIOTECH LLC
    Inventors: Gregory P. Dube, Zafiris W. Zafirelis, Anthony J. Laccetti, Javed Baqai
  • Publication number: 20080069771
    Abstract: An oxygenated Hemoglobin (Hb) solution includes from about 10 g to about 250 g of polymerized Hb per liter of solution. About 80% by weight, or greater, of the polymerized Hb of the oxygenated hemoglobin solution is oxyhemoglobin. About 18% by weight, or less, of the polymerized Hb has a molecular weight of over 500,000 Daltons. About 5% by weight, or less, of the polymerized Hb has a molecular weight equal to or less than 65,000 Daltons. A P50 of the polymerized Hb is in a range of between about 34 and about 46 mm Hg. An endotoxin content of the oxygenated Hb solution is less than about 0.05 endotoxin units per mL. A method of visualizing a tissue or organ of a subject includes the steps of administering to the subject an oxygenated hemoglobin solution as described above, and imaging the tissue, blood vessel or organ with an imaging system.
    Type: Application
    Filed: September 17, 2007
    Publication date: March 20, 2008
    Inventors: Anthony Laccetti, Javed Baqai
  • Patent number: 7001715
    Abstract: Red blood cells are purified by separating whole blood, such as by centrifugation, to form a red blood cell fraction and a liquid fraction. The whole blood can be defibrinated or treated to prevent coagulation prior to separation. Preferably, the whole blood is bovine blood. The red blood cell fraction is then diafiltered to purify the red blood cells. The purified red blood cells can then be lysed to form a lysate of purified red blood cells. The purified red blood cells and the lysate of purified red blood cells are suitable for use in producing hemoglobin blood substitute.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: February 21, 2006
    Assignee: Biopure Corporation
    Inventors: Robert A. Houtchens, Maria S. Gawryl, William R. Light, Javed Baqai
  • Publication number: 20030165573
    Abstract: Red blood cells are purified by separating whole blood, such as by centrifugation, to form a red blood cell fraction and a liquid fraction. The whole blood can be defibrinated or treated to prevent coagulation prior to separation. Preferably, the whole blood is bovine blood. The red blood cell fraction is then diafiltered to purify the red blood cells. The purified red blood cells can then be lysed to form a lysate of purified red blood cells. The purified red blood cells and the lysate of purified red blood cells are suitable for use in producing hemoglobin blood substitute.
    Type: Application
    Filed: February 28, 2002
    Publication date: September 4, 2003
    Applicant: Biopure Corporation
    Inventors: Robert A. Houtchens, Maria S. Gawryl, William R. Light, Javed Baqai